InvestorsHub Logo

Skipperdog11

08/20/22 1:38 PM

#386795 RE: Gusman #386779

"Closing Germany but getting an acceptable price in Nov 2022 might be part of a BO strategy."

I can certainly get behind that line of thought. Any of the Big Pharma companies would have no problem getting Germany signed. A simple solution would be to wait out the austerity crisis by putting the process on hold. Big Pharma can do this. Little Amarin cannot afford such luxury of time.